UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 16.

Baumann-Vogel, H; Valko, P O; Eisele, G; Baumann, C R (2015). Impulse control disorders in Parkinson's disease: don't set your mind at rest by self-assessments. European Journal of Neurology, 22(4):603-609.

Wolpert, F; Happold, C; Reifenberger, G; Florea, A M; Deenen, R; Roth, P; Neidert, M C; Lamszus, K; Westphal, M; Weller, M; Eisele, G (2015). Interferon-β modulates the innate immune response against glioblastoma initiating cells. PLoS ONE, 10(10):e0139603.

Wolpert, F; Tritschler, I; Steinle, A; Weller, M; Eisele, G (2014). A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells. Neuro-Oncology, 16(3):382-391.

Tonder, M; Weller, M; Eisele, G; Roth, P (2014). Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma. Chemotherapy, 60(5-6):375-378.

Eisele, G; Wick, A; Eisele, A C; Clément, P M; Tonn, J; Tabatabai, G; Ochsenbein, A; Schlegel, U; Neyns, B; Krex, D; Simon, M; Nikkhah, G; Picard, M; Stupp, R; Wick, W; Weller, M (2014). Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression. Journal of Neuro-Oncology, 117(1):141-145.

Roth, P; Stupp, R; Eisele, G; Weller, M (2014). Treatment of primary CNS lymphoma. Current Treatment Options in Neurology, 16(1):277.

Eisele, G; Wolpert, F; Decrey, G; Weller, M (2013). APO010, a synthetic hexameric CD95 ligand, induces death of human glioblastoma stem-like cells. Anticancer Research, 33(9):3563-3571.

Eisele, G; Weller, M (2013). Targeting apoptosis pathways in glioblastoma. Cancer Letters, 332(2):335-345.

Wolpert, F; Roth, P; Lamszus, K; Tabatabai, G; Weller, M; Eisele, G (2012). HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells. Journal of Neuroimmunology, 250(1-2):27-34.

Roth, P; Eisele, G; Weller, M (2012). Immunology of brain tumors. In: Aminoff, M; Boller, F; Swaab, D. Neuro-Oncology. Amsterdam: Elsevier, 45-51.

Schreglmann, S R; Gantenbein, A R; Eisele, G; Baumann, C R (2012). Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome. Parkinsonism & Related Disorders, 18(2):207-209.

Eisele, G; Roth, P; Hasenbach, K; Aulwurm, S; Wolpert, F; Tabatabai, G; Wick, W; Weller, M (2011). APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo. Neuro-Oncology, 13(2):155-164.

Roth, P; Wischhusen, J; Happold, C; Chandran, P A; Hofer, S; Eisele, G; Weller, M; Keller, A (2011). A specific miRNA signature in the peripheral blood of glioblastoma patients. Journal of Neurochemistry, 118(3):449-457.

Miller, J; Eisele, G; Tabatabai, G; Aulwurm, S; von Kürthy, G; Stitz, L; Roth, P; Weller, M (2010). Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma. Journal of Neurosurgery, 113(2):280-285.

Roth, P; Kissel, M; Herrmann, C; Eisele, G; Leban, J; Weller, M; Schmidt, F (2009). SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo. Clinical Cancer Research, 15(21):6609-6618.

Eisele, G; Roth, P; Wick, W; Weller, M (2008). MGMT in der klinischen Praxis. Onkologie Heute, 6(4):32-39.

This list was generated on Sat Jul 22 16:17:32 2017 CEST.